Home> Products> other anti estrogen therapies

{ "products": [ { "_id": "6662cb712bed1f08484d6d9c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Anastrozole 1 mg Tablet", "description": "ANASTRAZONE 1\nAnastrozole lp (1mg) \nAnastrozole 1 is a medication containing Anastrozole LP, with each tablet containing 1mg of the active ingredient. Anastrozole is classified as an aromatase inhibitor and is commonly prescribed for the treatment of hormone receptor-positive breast cancer in postmenopausal women. Here are key points about Anastrazone 1:\n\nMechanism of Action: Anastrozole works by inhibiting the enzyme aromatase, which is responsible for converting androgens into estrogens. By reducing estrogen levels in the body, Anastrozole helps in slowing down or stopping the growth of hormone-sensitive tumors.\n\nIndications: Anastrazone 1 is indicated for the adjuvant treatment of early hormone receptor-positive breast cancer in postmenopausal women. It may also be used in the treatment of advanced breast cancer in postmenopausal women who have not responded well to tamoxifen or other anti-estrogen therapies.\n\nDosage and Administration: The usual recommended dose of Anastrazone 1 is 1mg orally once daily, with or without food. It is important to follow the prescribed dosage and schedule as directed by your healthcare provider.\n\nSide Effects: Common side effects of Anastrazone 1 may include hot flashes, joint pain, headache, nausea, and weakness. Serious side effects such as bone fractures, cardiovascular events, and liver problems are rare but may occur.\n\nPrecautions: Before starting Anastrazone 1, inform your healthcare provider about any existing medical conditions, especially liver disease or osteoporosis. Regular monitoring of bone density and liver function may be recommended during treatment.\n\nDrug Interactions: Anastrazone 1 may interact with certain medications, including estrogen-containing products, tamoxifen, and some cholesterol-lowering drugs. Inform your doctor about all medications, supplements, and herbal products you are taking.\n\nPregnancy and Lactation: Anastrazone 1 is contraindicated during pregnancy and breastfeeding. It may cause harm to the unborn baby or nursing infant. Use effective contraception during treatment with Anastrazone 1 if you are of childbearing age.\n\nStorage: Store Anastrazone 1 at room temperature away from moisture and heat. Keep it out of reach of children and pets.\n\nAlways consult your healthcare provider for personalized guidance and information specific to your medical condition and treatment regimen.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n\n", "price": 402.0, "discountamount": 121.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "1mg", "Call", "body", "pets", "heat", "food", "harm", "Order", "Email", "reach", "growth", "Dosage", "nausea", "tablet", "doctor", "infant", "Storage", "moisture", "WhatsApp", "weakness", "headache", "schedule", "children", "Pregnancy", "Mechanism", "androgens", "estrogens", "Lactation", "tamoxifen", "medication", "key points", "joint pain", "Indications", "information", "Precautions", "supplements", "ANASTRAZONE", "unborn baby", "hot flashes", "osteoporosis", "sterisonline", "bone density", "breastfeeding", "liver disease", "liver function", "bone fractures", "Anastrozole LP", "liver problems", "Administration", "herbal products", "estrogen levels", "enzyme aromatase", "childbearing age", "room temperature", "active ingredient", "Drug Interactions", "treatment regimen", "Regular monitoring", "adjuvant treatment", "aromatase inhibitor", "Common side effects", "healthcare provider", "Serious side effects", "postmenopausal women", "cardiovascular events", "personalized guidance", "usual recommended dose", "advanced breast cancer", "effective contraception", "hormone-sensitive tumors", "cholesterol-lowering drugs", "existing medical conditions", "estrogen-containing products", "other anti-estrogen therapies", "early hormone receptor-positive breast cancer" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1517, "imageuri": "https://productimages.withfloats.com/actual/667d31e6576e8da931df6df3.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d31e6576e8da931df6df3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T08:57:21.017Z", "updatedon": "2025-12-04T06:47:20.829Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/anastrozole-1-mg-tablet/1517", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ANASTRAZONE 1 ", "category": "Oncology", "tags": [ "anastrozole 1 mg tablet uses", "anastrozole 1 mg tablet brand name", "anastrozole 1 mg tablet uses", "Anastrozole helps in slowing down or stopping the growth of hormone-sensitive tumors.", "breast cancer", "anti-estrogen therapies", "breast cancer in postmenopausal" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "693c0a0eb7439f8802544bc8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "RIBAVIRIN CAPSULES IP 100mg", "description": "REBATERIS 100 contains Ribavirin IP 100mg in a hard gelatin capsule filled with white to off-white powder for optimal stability and bioavailability. Each pack typically includes 30 capsules, designed for oral administration with food to enhance absorption and reduce gastrointestinal upset. Ribavirin, a synthetic guanosine nucleoside analog, interferes with viral RNA polymerase and mRNA capping, halting hepatitis C virus (HCV) replication at multiple stages. This broad-spectrum antiviral also shows activity against respiratory syncytial virus (RSV) in select pediatric cases, though its primary indication remains HCV genotype management.​\n\nThe 100mg strength allows for weight-based dosing adjustments, making REBATERIS 100 suitable for adults and children over 3 years under specialist supervision. Unlike higher 200mg capsules, it supports finer dose reductions during therapy to manage side effects, ensuring better tolerability. Stored at room temperature away from moisture, it maintains potency for extended shelf life, aligning with pharmacopeial standards for purity and dissolution.​\n\nKey Uses\nREBATERIS 100 treats chronic hepatitis C virus infection in combination therapies, particularly for patients ineligible for all-oral direct-acting antivirals. It boosts sustained virologic response rates when paired with pegylated interferon alfa, addressing genotypes 1 through 6 based on regional guidelines.​\n\nIn severe RSV lower respiratory tract infections, off-label use occurs in hospitalized infants, where aerosolized forms predominate, but oral REBATERIS 100 contributes to interferon combos for immunocompromised children. It curbs viral load, prevents liver fibrosis progression, and reduces cirrhosis risk, making it essential for long-term liver preservation.​\n\nAdditionally, emerging evidence supports its adjunct role in certain hemorrhagic fevers like Lassa virus, though availability limits widespread application. Always initiated by hepatologists, treatment durations span 24-48 weeks depending on genotype, viral load, and response milestones.​\n\nMajor Benefits\nREBATERIS 100 enhances viral clearance, achieving up to 50-80% sustained response rates in interferon combinations, significantly lowering hepatocellular carcinoma risk over five years. Patients experience normalized liver enzymes and fibrosis regression on biopsy follow-up.​\n\nIts oral capsule form simplifies adherence compared to injectables, with twice-daily dosing fitting daily routines. The 100mg potency permits precise titration—e.g., 800-1400mg daily divided—for personalized therapy, minimizing excess exposure in lighter patients.​\n\nLong-term, it preserves liver function, averting transplants and improving quality of life metrics like fatigue reduction and work productivity. Cost-effective for resource-limited settings, REBATERIS 100 bridges gaps until pan-genotypic regimens become accessible.​\nBenefit\tMechanism\tClinical Impact\nViral Suppression\tRNA polymerase inhibition ​\t>50% SVR in combos ​\nLiver Protection\tFibrosis halt ​\tReduced cirrhosis by 30-40%\nFlexible Dosing\t100mg increments ​\tBetter tolerability, adherence\nBroad Genotype Coverage\tMulti-genotype efficacy ​\tVersatile for diverse patients\nPotential Side Effects\nCommon side effects include hemolytic anemia, peaking at weeks 4-8, necessitating hemoglobin monitoring and dose cuts to 600mg daily if levels drop below 10g/dL. Fatigue, headache, and insomnia affect over 40% of users, often resolving post-therapy.​\n\nGastrointestinal issues like nausea, diarrhea, and anorexia occur in 20-30%, mitigated by food intake. Dermatologic reactions—rash, pruritus—or flu-like symptoms from interferon pairing demand vigilance. Teratogenicity risks are high; dual contraception is mandatory for 6 months post-treatment due to sperm/ovum mutagenicity.​\n\nSerious risks encompass pulmonary infiltrates, cardiac ischemia in vulnerable patients, and thyroid dysfunction. Avoid in hemoglobinopathies, severe renal impairment (CrCl <50mL/min), or pregnancy. Regular blood counts and ophthalmologic exams guide safe continuation.​\n\nDosage Guidelines\nDosing is weight-based: adults <75kg receive mg/day (10 capsules: 5 AM, 5 PM); ≥75kg get 1200 mg/day (12 capsules: 6 AM, 6 PM), swallowed whole with meals. Pediatrics (≥3 years): 15mg/kg/day divided BID, rounded to the nearest 100mg via REBATERIS 100 capsules.​\n\nReduce by 200-400mg for anemia or neutropenia; discontinue if unresolved. Duration: 48 weeks for genotype 1, 24 weeks for others, with viral load checks at week 12. Swallow intact; no crushing.​\nConclusion\nREBATERIS 100 empowers hepatitis C management with proven antiviral potency and dosing precision from Steris Healthcare. It transforms prognosis for countless patients, but demands specialist oversight amid monitoring needs", "price": 2900.0, "discountamount": 870.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2242, "imageuri": "https://productimages.withfloats.com/actual/693c0a151c130ff8f4cd2c93.png", "tileimageuri": "https://productimages.withfloats.com/tile/693c0a151c130ff8f4cd2c93.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-12T12:26:54.651Z", "updatedon": "2025-12-12T12:26:54.651Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ribavirin-capsules-ip-100mg/2242", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "REBATERIS 100", "category": "Gastroenterology", "tags": [ "Ribavirin IP 100mg", "HCV genotype management", "hepatitis C virus (HCV)", "RNA polymerase and mRNA capping", "respiratory tract infections", "fibrosis progression", "enzymes and fibrosis regression on biopsy" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6937c92e461b07808ef722e4", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Cyclosporine 100mg", "description": "Cyclosporine, marketed under the brand name CYCLOPURE 100, is a potent immunosuppressant medication widely used in clinical settings to prevent organ transplant rejection and to manage various autoimmune disorders. Available as a 100mg oral capsule, CYCLOPURE 100 plays a critical role in modulating the immune system, helping patients maintain graft survival and control symptoms of immune-related diseases.\n\nProduct Description\nCYCLOPURE 100 contains cyclosporine, a cyclic polypeptide consisting of 11 amino acids, derived from the fungus Tolypocladium inflatum. It selectively inhibits the activity of T-lymphocytes, a subset of white blood cells that play a central role in immune response. By targeting these immune cells, cyclosporine helps prevent the body’s immune system from attacking transplanted organs, such as kidneys, liver, or heart, and reduces inflammation in autoimmune diseases.\n\nThe capsules are formulated for oral administration, with each capsule containing 100mg of cyclosporine. This dosage provides an effective balance between immunosuppression and safety for most adult patients, although dosing must be carefully tailored by healthcare providers based on patient response, therapeutic drug monitoring, and condition severity.\n\nUses of CYCLOPURE 100\nCYCLOPURE 100 is primarily indicated for the following medical purposes:\n\nPrevention of Organ Transplant Rejection: It is commonly prescribed to recipients of kidney, liver, heart, or other organ transplants to prevent acute and chronic rejection by suppressing immune responses that target the graft.\n\nAutoimmune Disease Management: Cyclosporine is effective in treating autoimmune disorders such as rheumatoid arthritis, psoriasis, and certain types of nephrotic syndrome. By reducing immune system overactivity, it helps alleviate symptoms such as joint inflammation, skin lesions, and kidney damage.\n\nSevere Atopic Dermatitis: In cases where conventional treatments are ineffective, cyclosporine may be used to control symptoms of severe eczema by modulating immune hyper-reactivity.\n\nOther Off-Label Uses: Occasionally, cyclosporine is used for other immune-mediated conditions like uveitis, Crohn’s disease, and some forms of lupus nephritis depending on physician discretion.\n\nKey Benefits\nEffective Immunosuppression: CYCLOPURE 100 is known for its potent ability to suppress immune responses selectively, significantly reducing the risk of organ rejection after transplantation and improving graft survival rates.\n\nVersatility in Autoimmune Conditions: Beyond organ transplantation, cyclosporine’s immunomodulatory effects provide relief in autoimmune diseases by controlling inflammation and immune overactivity that cause tissue damage.\n\nImprovement in Quality of Life: By controlling disease symptoms such as joint pain, skin inflammation, or kidney impairment, CYCLOPURE 100 enables patients to experience improved physical comfort and daily functioning.\n\nOral Administration Convenience: The capsule form ensures ease of use and better patient compliance compared to injectable immunosuppressants, allowing therapy to be managed on an outpatient basis.\n\nTherapeutic Drug Monitoring: The availability of blood level monitoring helps customize dosage and maximize therapeutic effects while minimizing toxicity.\n\nSide Effects and Precautions\nWhile CYCLOPURE 100 is highly beneficial, it carries a risk of side effects due to its immunosuppressive nature and systemic effects. Common, less severe side effects include:\n\nGingival hyperplasia (gum overgrowth)\n\nTremors or mild neurological symptoms\n\nHypertension (high blood pressure)\n\nIncreased hair growth (hypertrichosis)\n\nGastrointestinal disturbances (nausea, diarrhea)\n\nMore serious adverse effects, which require immediate medical attention, can include:\n\nNephrotoxicity: Cyclosporine can affect kidney function; regular monitoring of kidney function tests is essential.\n\nIncreased Risk of Infections: Suppression of the immune system increases vulnerability to bacterial, viral, and fungal infections.\n\nHepatotoxicity: Liver function should be monitored as cyclosporine may cause elevated liver enzymes or more severe liver damage.\n\nMalignancies: Long-term use has been associated with an increased risk of certain cancers, particularly lymphomas and skin cancers.\n\nElectrolyte Imbalances: Hypomagnesemia and hyperkalemia are possible and require monitoring.\n\nPatients must inform their healthcare providers about other medications they take, as cyclosporine has significant drug interactions that can affect its blood levels and toxicity risk, including with antibiotics, antifungals, anticonvulsants, and others.\n\nConclusion\nCYCLOPURE 100 (Cyclosporine 100mg) stands as a cornerstone immunosuppressant medication that plays a vital role in preventing organ rejection and managing autoimmune diseases. Its targeted immunosuppressive action effectively reduces disease burden, enhances graft survival, and improves patients’ quality of life. Although it entails risks of side effects, careful medical supervision, therapeutic drug monitoring, and adherence to prescribed dosing protocols effectively mitigate these concerns.\n\nFor patients undergoing organ transplantation or those with autoimmune conditions unresponsive to standard therapies, CYCLOPURE 100 provides a valuable therapeutic solution. Always consult a healthcare professional before starting or adjusting therapy with CYCLOPURE 100 to ensure the safest and most effective use tailored to individual clinical needs.", "price": 1014.0, "discountamount": 305.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2239, "imageuri": "https://productimages.withfloats.com/actual/6937c930ed26b2c06ce34f7e.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/6937c930ed26b2c06ce34f7e.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-09T07:01:02.399Z", "updatedon": "2025-12-09T07:01:02.399Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cyclosporine-100mg/2239", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CYCLOPURE 100", "category": "NEUROLOGY RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69327c28991683751071b8b8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Polmacoxib 2mg , Paracetamol 325mg", "description": "PUMACOXIB PCM, featuring Polmacoxib 2mg and Paracetamol 325mg, delivers targeted relief from pain, inflammation, and fever associated with conditions like osteoarthritis and rheumatoid arthritis. This combination tablet works synergistically, with Polmacoxib inhibiting the COX-2 enzyme to curb inflammatory prostaglandins, while Paracetamol blocks pain signals in the brain. Patients often experience faster mobility and daily comfort from this dual-action formula.​\n\nProduct Overview and Composition\nPUMACOXIB PCM stands out as a modern pharmaceutical solution crafted for effective management of acute and chronic pain issues. Each tablet contains precisely 2mg of Polmacoxib, a selective COX-2 inhibitor that precisely targets inflammation without broadly affecting other body processes, and 325mg of Paracetamol, a trusted analgesic and antipyretic. This balanced formulation ensures comprehensive coverage against discomfort from joint disorders, muscle strains, or post-injury swelling.​\n\nThe medication's design emphasizes safety and efficacy, making it suitable for ortho patients and those with inflammatory conditions. Produced under high-quality standards, PUMACOXIB PCM offers a convenient single-dose approach to symptom control. Regular use as prescribed supports sustained joint health and reduces reliance on multiple drugs.​\n\nKey Uses of PUMACOXIB PCM\nPUMACOXIB PCM proves highly effective for osteoarthritis, particularly in hip and knee joints, where it alleviates pain, stiffness, and swelling. Rheumatoid arthritis patients benefit from its ability to ease flare-ups, improving grip strength and movement. It also addresses general body aches, back pain, and muscle soreness from injuries or overuse.​\n\nBeyond arthritis, the tablet manages post-surgical discomfort and inflammatory responses in conditions like tendonitis. For fever accompanying pain, such as in flu-related joint issues, Paracetamol component provides prompt temperature reduction. Healthcare providers often recommend it for short-term acute pain or longer-term chronic management under supervision.​\n\nMajor Benefits and Advantages\nOne primary benefit of PUMACOXIB PCM lies in its rapid onset, delivering long-lasting pain relief that enhances daily activities without constant redosing. The selective COX-2 action of Polmacoxib minimizes gastrointestinal risks compared to traditional NSAIDs, allowing safer use for stomach-sensitive individuals. Combined with Paracetamol, it offers fever control alongside anti-inflammatory effects, creating a versatile tool for multifaceted symptoms.​\n\nUsers report improved mobility and quality of life, with reduced joint stiffness enabling better exercise adherence and work productivity. Its lower side effect profile supports extended use in chronic cases, outperforming single-agent therapies in noninferiority studies against alternatives like etoricoxib combinations. Overall, PUMACOXIB PCM promotes holistic pain management with fewer disruptions to routine.​\n\nFast-acting dual relief for pain and swelling.​\n\nEnhanced joint flexibility for arthritis sufferers.​\n\nSafer stomach profile for prolonged therapy.​\n\nConvenient all-in-one tablet for busy lifestyles.​\n\nPotential Side Effects and Precautions\nWhile generally well-tolerated, PUMACOXIB PCM may cause mild effects like nausea, headache, or dizziness in some users, often resolving without intervention. Rare risks include allergic reactions such as rash or swelling, requiring immediate medical attention. Liver concerns arise with Paracetamol overuse, so adherence to dosage—one to two tablets daily—remains crucial.​\n\nAvoid alcohol to prevent liver strain, and consult doctors for kidney, liver, or heart conditions before starting. Pregnant or breastfeeding individuals should seek guidance, as should those on blood thinners or other medications. Monitoring ensures optimal safety, with most experiencing minimal issues at recommended levels.​\n\nCommon Side Effects\tLess Common Risks\tManagement Tips\nNausea, dizziness ​\tAllergic rash, swelling ​\tTake with food; hydrate well\nHeadache ​\tLiver strain (overdose) ​\tFollow dosage; avoid alcohol\nStomach discomfort ​\tHeart-related (rare) ​\tConsult for pre-existing issues\nDosage Guidelines and Best Practices\nSwallow PUMACOXIB PCM whole with water, once or twice daily, adjusting per physician advice based on pain severity. It works with or without meals, though food may ease minor stomach upset. For acute pain, short courses suffice; chronic use needs regular check-ups.​\n\nDo not exceed prescribed amounts to safeguard against Paracetamol accumulation. Store in a cool, dry place away from children. Integrating lifestyle changes like light exercise amplifies results.​\n\nConclusion\nPUMACOXIB PCM with Polmacoxib 2mg and Paracetamol 325mg transforms pain management by blending potent anti-inflammatory and analgesic actions into one reliable tablet. Its benefits in reducing inflammation, easing pain, and boosting mobility make it ideal for arthritis and related woes, all while prioritizing a favorable safety profile. Choose PUMACOXIB PCM for empowered, discomfort-free living—consult your healthcare provider today to integrate it into your wellness plan.​", "price": 295.0, "discountamount": 89.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2232, "imageuri": "https://productimages.withfloats.com/actual/69327c296111c1dae707ef57.png", "tileimageuri": "https://productimages.withfloats.com/tile/69327c296111c1dae707ef57.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-05T06:31:04.077Z", "updatedon": "2025-12-05T06:31:04.077Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/polmacoxib-2mg-paracetamol-325mg/2232", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PUMACOXIB PCM", "category": "ORTHOPEDICS RANGE", "tags": [ "Polmacoxib 2mg and Paracetamol 325mg", "Paracetamol blocks pain signals in the brain", "PUMACOXIB PCM,", "Polmacoxib 2mg and Paracetamol 325mg transforms pain" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6926eb5b4c6b1fd261aeb36d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Levosalbutamol Respiratory Solution 0.63 mg", "description": "Levosalbutamol Respiratory Solution 0.63 mg is a fast-acting bronchodilator medication designed to relieve bronchospasm and improve breathing in conditions such as asthma, chronic obstructive pulmonary disease (COPD), bronchitis, and other respiratory difficulties. Its active ingredient, levosalbutamol, works by relaxing the muscles lining the airways in the lungs, helping to open up the bronchial tubes and making it easier for air to flow through. This leads to quick reduction of symptoms such as wheezing, coughing, chest tightness, and shortness of breath, providing immediate relief during an asthma attack or respiratory flare-up.\n\nThe primary use of Levosalbutamol Respiratory Solution is to manage reversible obstructive airway diseases. It is especially effective during acute episodes of bronchospasm where rapid opening of the airways is necessary. Patients with asthma benefit from this solution as it reduces the intensity and frequency of attacks while improving overall lung function. It is also widely prescribed for COPD patients to alleviate persistent respiratory symptoms and prevent worsening of their condition. Delivered via nebulization, the solution ensures direct medication delivery to the lungs, maximizing therapeutic effects for quick symptom relief.\n\nKey benefits of Levosalbutamol Respiratory Solution 0.63 mg include:\n\nRapid bronchodilation resulting in immediate relief from airway constriction.\n\nImproved airflow and oxygen delivery enhancing breathing and physical activity tolerance.\n\nReduction in common respiratory symptoms like wheezing, coughing, and chest tightness.\n\nEffective management of both acute asthma attacks and chronic respiratory conditions.\n\nSuitable for use under medical supervision in adults and children aged four years and older.\n\nWhile Levosalbutamol is generally well-tolerated, some side effects may occur. Common mild side effects include tremors, nervousness, headache, dizziness, and palpitations. Gastrointestinal complaints like nausea or dry mouth can also be experienced occasionally. These effects are usually transient and resolve with continued use or dosage adjustment. More serious, though less frequent, side effects could include rapid or irregular heartbeats, chest pain, muscle cramps, or allergic reactions characterized by rash, swelling, or difficulty breathing. If any severe side effects arise, prompt medical attention is necessary.\n\nIn conclusion, Levosalbutamol Respiratory Solution 0.63 mg offers an effective and reliable treatment option for managing bronchospasm in asthma and COPD patients. Its mechanism of action ensures fast relief from breathing difficulties by relaxing airway muscles and enhancing airflow. When used as prescribed by healthcare professionals, it substantially improves the quality of life by controlling respiratory symptoms and preventing exacerbations. Patients should be mindful of potential side effects and follow dosage guidelines closely to maximize benefits while minimizing risks.\nThis respiratory solution by Steris Healthcare provides a safe, user-friendly option for individuals requiring quick bronchodilation and respiratory symptom management. It is part of a comprehensive asthma or COPD management plan that includes preventive therapies, lifestyle adjustments, and regular medical monitoring to optimize respiratory health.", "price": 36.0, "discountamount": 11.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2219, "imageuri": "https://productimages.withfloats.com/actual/6926eb5f71494d31a6ac98f4.png", "tileimageuri": "https://productimages.withfloats.com/tile/6926eb5f71494d31a6ac98f4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-26T11:58:19.908Z", "updatedon": "2025-12-01T09:18:13.97Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/levosalbutamol-respiratory-solution-0-63-mg/2219", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "THEO-SLO LEVO 0.63", "category": "ASTHMA RANGE", "tags": [ "Levosalbutamol Respiratory Solution 0.63 mg", "chronic obstructive pulmonary disease", "respiratory symptoms", "coughing", "breathing" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6916c002d152b8cabef859ea", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Miltefosine Capsules", "description": "Miltefosine Capsules are an important oral medication widely recognized for their effectiveness in treating Visceral Leishmaniasis (Kala-azar), Cutaneous Leishmaniasis, and certain protozoal infections. As the first and only oral drug approved for the treatment of Leishmaniasis, Miltefosine has significantly transformed patient care by offering a convenient and reliable alternative to painful injectable therapies. The medication belongs to the class of alkylphosphocholine drugs and is known for its potent antiparasitic and cytotoxic actions.\n\nMiltefosine Capsules are typically prescribed by healthcare professionals when a confirmed diagnosis of Leishmaniasis has been made, or when the patient is not responding adequately to other modes of therapy. Its high absorption rate, ease of administration, and consistent therapeutic activity make it a cornerstone in parasitic infection management across endemic regions.\n\nWhat Are Miltefosine Capsules?\n\nMiltefosine is an oral antiparasitic medication designed to eliminate Leishmania parasites by disrupting their cell membranes and metabolic functions. It was originally studied for anticancer activities but later found to be highly effective against various Leishmania species. Unlike conventional treatment options that require hospitalization and injections, Miltefosine offers a non-invasive, at-home oral therapy option, improving both patient comfort and compliance.\n\nMiltefosine Capsules are generally marketed in different strengths such as 50 mg. The duration of treatment usually ranges between 28–30 days depending on the medical condition and severity.\n\nUses of Miltefosine Capsules\n\nMiltefosine Capsules are primarily prescribed for:\n\n1. Visceral Leishmaniasis (Kala-azar)\n\nThis is a severe, life-threatening parasitic disease affecting internal organs such as the spleen, liver, and bone marrow. Miltefosine is considered one of the most effective oral treatment options for Kala-azar and is widely used in India and other tropical regions where the disease is endemic.\n\n2. Cutaneous Leishmaniasis\n\nIt causes skin lesions, ulcers, and disfiguring scars. Miltefosine works by targeting the parasite in skin tissues, promoting faster healing and reducing complications.\n\n3. Mucocutaneous Leishmaniasis\n\nThough less common, this form affects mucous membranes of the nose, mouth, and throat. Miltefosine plays a major role in preventing progressive tissue destruction.\n\n4. Off-Label Uses\n\nIn some cases, doctors may prescribe Miltefosine for:\n\nCertain protozoal infections\n\nAmoebic keratitis (rare condition affecting the eye)\n\nParasitic infections resistant to other treatments\n\nHowever, these uses should only be followed under strict medical supervision.\n\nHow Miltefosine Works\n\nMiltefosine acts directly on parasitic cells by:\n\nDisrupting cell membrane integrity\n\nInterfering with phospholipid metabolism\n\nTriggering apoptosis-like cell death in parasites\n\nWeakening parasite reproduction and survival\n\nThis multi-target mechanism makes Miltefosine one of the most powerful oral antiparasitic medications available today.\n\nKey Benefits of Miltefosine Capsules\n1. Highly Effective Oral Treatment\n\nUnlike older treatments requiring multiple injections, Miltefosine provides a simple oral dosage, eliminating the need for hospitalization or painful procedures.\n\n2. Excellent Patient Compliance\n\nThe convenience of taking capsules at home significantly improves adherence to treatment, especially in rural or resource-limited areas.\n\n3. Strong Activity Against Leishmania Species\n\nMiltefosine’s broad-spectrum antiparasitic properties make it effective against several strains of Leishmania responsible for different clinical presentations of the disease.\n\n4. Lower Risk of Severe Treatment Complications\n\nCompared to traditional injectable therapies like antimonials, Miltefosine has a better safety profile when used under medical supervision.\n\n5. Reduces Disease Transmission\n\nBy effectively eliminating parasites from the body, Miltefosine helps reduce the overall disease burden in endemic communities.\n\n6. Faster Healing of Skin Lesions\n\nPatients with Cutaneous Leishmaniasis experience faster recovery, reduced lesion size, and minimal scarring when treatment is taken on time.\n\n7. Well-Studied and Recommended\n\nMiltefosine is recommended by WHO and national health authorities in many countries as a frontline treatment for Kala-azar.\n\nPossible Side Effects of Miltefosine Capsules\n\nWhile generally well tolerated, Miltefosine may cause certain side effects. Most of these are mild to moderate and subside as the body adapts to the medication.\n\nCommon Side Effects\n\nNausea and vomiting\n\nDiarrhea\n\nAbdominal discomfort\n\nLoss of appetite\n\nTemporary weakness or fatigue\n\nModerate Side Effects\n\nElevated liver enzymes\n\nMild kidney function changes\n\nSkin reactions such as redness or itching\n\nSevere, But Less Common Side Effects\n\nNephrotoxicity (kidney-related issues)\n\nHepatotoxicity (liver-related issues)\n\nSevere gastrointestinal upset\n\nVision-related disturbances in very rare cases\n\nImportant Warning for Women\n\nMiltefosine is NOT recommended during pregnancy as it can cause fetal harm. Women of childbearing age must use reliable contraception during treatment and for at least 3 months after therapy.\n\nPrecautions\n\nPatients with the following conditions should use Miltefosine cautiously:\n\nLiver or kidney disease\n\nPregnancy or breastfeeding\nSevere dehydration\nUncontrolled vomiting or diarrhea\n\nAlways follow the dosage exactly as prescribed by a healthcare professional.\n\nConclusion\n\nMiltefosine Capsules have revolutionized the treatment of various forms of Leishmaniasis by offering a powerful, effective, and convenient oral therapy option. Their ability to target parasitic infections through multiple mechanisms makes them a trusted solution in endemic regions. Whether used for Visceral, Cutaneous, or Mucocutaneous Leishmaniasis, Miltefosine provides significant therapeutic benefits, faster recovery, and improved patient compliance.", "price": 1350.0, "discountamount": 405.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2205, "imageuri": "https://productimages.withfloats.com/actual/6916c0042444cd45b3f0f253.png", "tileimageuri": "https://productimages.withfloats.com/tile/6916c0042444cd45b3f0f253.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-14T05:37:06.048Z", "updatedon": "2025-12-09T05:59:01.077Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/miltefosine-capsules/2205", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MILTEFOSE 50", "category": "GENERAL RANGE", "tags": [ "Miltefosine Capsules", "Visceral Leishmaniasis (Kala-azar)", "protozoal infections", "Cutaneous Leishmaniasis" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6914279954622e7e8d289f59", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Milk Thistle Extract, L-Ornithin, Inositol, and essential multivitamin Capsules", "description": "Milk Thistle Extract, L-Ornithine, Inositol with Multivitamin Softgel Capsules is a powerful herbal-nutrient formulation designed to promote liver health, detoxification, and metabolic balance while supporting overall vitality and cellular protection. This unique blend combines the traditional hepatoprotective benefits of Milk Thistle with the amino acid L-Ornithine, the metabolic regulator Inositol, and a comprehensive spectrum of essential vitamins and antioxidants that nourish and rejuvenate the body from within.\n\nThe formulation is specifically developed to support liver function, enhance detoxification, improve fat metabolism, and protect the body against oxidative stress caused by toxins, alcohol, medications, and environmental pollutants. It is ideal for individuals experiencing fatigue, poor digestion, or those exposed to hepatic stress due to lifestyle or medication use.\n\nComposition (Typical Formula per Softgel)\n\nEach softgel capsule may contain:\n\nMilk Thistle Extract (Silybum marianum) – Standardized to contain Silymarin 80%\n\nL-Ornithine L-Aspartate – 150 mg (or as per formulation)\n\nInositol – 100 mg\n\nMultivitamins:\n\nVitamin A\n\nVitamin C\n\nVitamin E\n\nVitamin B-Complex (B1, B2, B3, B5, B6, B12, Folic Acid, Biotin)\n\nVitamin D3\n\nMinerals (Zinc, Selenium, Magnesium – optional depending on brand)\n\nEncapsulated in soft gelatin capsules to ensure maximum absorption, stability, and bioavailability.\n\nMechanism of Action\n\nThis formulation provides a synergistic hepatoprotective and metabolic effect through the combined action of its components:\n\nMilk Thistle Extract (Silymarin):\nActs as a powerful antioxidant and liver cell regenerator. Silymarin stabilizes hepatocyte membranes, promotes protein synthesis, and enhances the regeneration of damaged liver cells. It also prevents toxins from binding to liver receptors, reducing the harmful effects of alcohol, drugs, and environmental chemicals.\n\nL-Ornithine L-Aspartate:\nSupports ammonia detoxification in the liver by converting toxic ammonia into urea, which is safely excreted by the kidneys. This helps reduce fatigue and cognitive impairment associated with high ammonia levels and supports liver function in cases of hepatic stress.\n\nInositol:\nA vital nutrient for fat metabolism and liver lipid regulation. It assists in breaking down fats, prevents fat accumulation in the liver (hepatic steatosis), and supports proper nerve function and mental clarity.\n\nMultivitamins and Antioxidants:\nProvide broad-spectrum nutritional support, improving immune function, energy metabolism, and cellular defense. Vitamins C and E protect cells from oxidative damage, while the B-complex group enhances liver enzyme activity and promotes overall metabolic efficiency.\n\nUses and Indications\n\nMilk Thistle Extract, L-Ornithine, Inositol with Multivitamin Softgel Capsules is recommended for:\n\nLiver Protection and Detoxification:\n\nHelps in liver cell regeneration and protects against hepatotoxic substances like alcohol, drugs, and pollutants.\n\nAssists in managing fatty liver disease, alcoholic liver damage, and drug-induced liver injury.\n\nSupportive Therapy in Liver Disorders:\n\nAdjuvant in hepatitis, jaundice, and cirrhosis.\n\nUseful for individuals with elevated liver enzymes or chronic liver stress.\n\nEnhanced Metabolic Function:\n\nPromotes detoxification of ammonia and other metabolic by-products.\n\nSupports energy metabolism and reduces fatigue.\n\nLipid Regulation and Fat Metabolism:\n\nInositol aids in the breakdown and transport of fats, preventing fat accumulation in liver cells.\n\nBeneficial in non-alcoholic fatty liver (NAFLD).\n\nGeneral Health and Immunity:\n\nStrengthens the body’s antioxidant defense system.\n\nProvides essential vitamins to enhance immunity, improve skin and hair health, and boost overall energy levels.\n\nKey Benefits\n\nPowerful Liver Support:\n\nSilymarin from Milk Thistle safeguards liver cells from oxidative and chemical damage.\n\nPromotes detoxification and regeneration of hepatocytes.\n\nEnhanced Detoxification:\n\nL-Ornithine facilitates removal of harmful ammonia and supports healthy liver metabolism.\n\nImproved Fat and Lipid Metabolism:\n\nInositol helps regulate cholesterol and prevents fat accumulation in the liver, reducing risk of fatty liver disease.\n\nAntioxidant Protection:\n\nVitamins C and E combat free radicals, reducing cellular damage and slowing aging processes.\n\nEnergy and Vitality Boost:\n\nB-complex vitamins aid in energy production and metabolic efficiency, reducing fatigue and weakness.\n\nComprehensive Nutritional Support:\n\nProvides essential micronutrients for optimal organ function, immunity, and cellular repair.\n\nSupports Recovery from Alcohol or Drug Use:\n\nAids detoxification and replenishes nutrients depleted by alcohol, medications, or poor diet.\n\nConvenient and Well-Tolerated:\n\nSoftgel form ensures easy swallowing, rapid absorption, and minimal gastrointestinal discomfort.\n\nSide Effects and Precautions\n\nWhile generally safe and well-tolerated, some individuals may experience mild, temporary side effects:\n\nGastrointestinal Discomfort:\n\nMild nausea, bloating, or stomach upset may occur in sensitive individuals.\n\nAllergic Reactions:\n\nRarely, people allergic to plants of the Asteraceae family (like daisies or ragweed) may react to Milk Thistle.\n\nLoose Stools or Diarrhea:\n\nOccasionally due to the detoxifying effect on the digestive system.\n\nHeadache or Fatigue:\n\nRare and usually transient.\n\nPrecautions:\n\nPregnant or lactating women should use under medical supervision.\n\nIndividuals with hormone-sensitive conditions (due to phytoestrogenic nature of Milk Thistle) should consult a doctor before use.\n\nPatients with chronic liver disease, diabetes, or taking other hepatotoxic drugs should take the supplement under medical guidance.\n\nAvoid overdose; follow the recommended dosage strictly.\n\nRecommended Dosage\n\nAdults: One softgel capsule once or twice daily, or as directed by a healthcare professional.\n\nBest taken after meals with water for optimal absorption.\n\nStorage and Handling\n\nStore below 25°C, protected from moisture and direct sunlight.\n\nKeep out of reach of children.\n\nDo not use if the seal is broken or the capsule appears damaged.\n\nConclusion\n\nMilk Thistle Extract, L-Ornithine, Inositol with Multivitamin Softgel Capsules represents a scientifically balanced and holistic approach to liver care and metabolic wellness. Combining the ancient herbal wisdom of Milk Thistle with modern nutritional science, this formulation works synergistically to detoxify, protect, and revitalize the liver while supporting overall body health.", "price": 245.0, "discountamount": 73.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2201, "imageuri": "https://productimages.withfloats.com/actual/6914279b5b13e020f30fd22d.png", "tileimageuri": "https://productimages.withfloats.com/tile/6914279b5b13e020f30fd22d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-12T06:22:17.19Z", "updatedon": "2025-12-09T05:59:22.679Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/milk-thistle-extract-l-ornithin-inositol-and-essential-multivitamin-capsules/2201", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "STERIMMUNE LIVERMAX", "category": "NEPHROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6908575f0c31b1295dc50d7e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Ursodeoxycholic Acid 600 mg", "description": "Ursodeoxycholic Acid 600 mg is a clinically trusted and widely prescribed medication used in the management of liver and gallbladder disorders. Belonging to the class of bile acid derivatives, it plays a vital role in improving liver function and dissolving certain types of gallstones without surgery. This medicine is commonly prescribed to patients suffering from cholestatic liver diseases, such as primary biliary cholangitis (PBC), non-alcoholic fatty liver disease (NAFLD), and bile reflux gastritis.\n\nIn the Indian healthcare setting, Ursodeoxycholic Acid (also known as UDCA) has become a cornerstone therapy for liver protection. It is known not only for its effectiveness in improving bile flow but also for its anti-inflammatory, immunomodulatory, and cytoprotective properties. The 600 mg strength formulation provides an optimal dose for adult patients, ensuring consistent bile regulation and liver cell protection.\n\nProduced under stringent quality control by leading pharmaceutical companies like Steris Healthcare Pvt. Ltd., Ursodeoxycholic Acid 600 mg ensures purity, efficacy, and patient safety. This makes it a dependable choice for clinicians and patients managing chronic liver diseases in India.\n\nWhat is Ursodeoxycholic Acid?\n\nUrsodeoxycholic Acid (UDCA) is a naturally occurring bile acid that is present in small amounts in the human body. It is synthesized and used as a medication to treat liver and gallbladder conditions by altering bile composition and reducing the production of toxic bile acids.\n\nChemically, Ursodeoxycholic Acid is a hydrophilic bile acid, meaning it has a high affinity for water and helps replace harmful hydrophobic bile acids that can damage liver cells. It is known for its ability to protect hepatocytes (liver cells) from injury, enhance bile secretion, and dissolve cholesterol-based gallstones.\n\nBy reducing bile cholesterol saturation and promoting bile flow, UDCA helps maintain liver function, especially in conditions where bile flow is obstructed or impaired.\n\nMechanism of Action\n\nThe therapeutic action of Ursodeoxycholic Acid is multifaceted:\n\nBile Flow Regulation:\nUDCA improves bile secretion and reduces bile stasis (retention). This helps in clearing toxic bile acids from the liver, thereby preventing inflammation and fibrosis.\n\nCytoprotective Effect:\nIt stabilizes the hepatocyte (liver cell) membrane and reduces damage caused by bile acid-induced oxidative stress.\n\nImmunomodulatory Action:\nUrsodeoxycholic Acid reduces autoimmune destruction of bile ducts in diseases like primary biliary cholangitis by modulating immune response.\n\nCholesterol Reduction:\nUDCA decreases the cholesterol content of bile and suppresses hepatic cholesterol synthesis, leading to the gradual dissolution of cholesterol gallstones.\n\nAntifibrotic and Anti-inflammatory Role:\nBy reducing inflammation and fibrosis markers, UDCA helps slow the progression of chronic liver diseases.\n\nTherapeutic Uses of Ursodeoxycholic Acid 600 mg\n\nUrsodeoxycholic Acid 600 mg tablets are prescribed for a wide range of liver and gallbladder-related conditions. Below are the major medical indications:\n\n1. Primary Biliary Cholangitis (PBC):\n\nOne of the most common uses of UDCA is in treating primary biliary cholangitis, an autoimmune condition that causes slow, progressive destruction of bile ducts within the liver. Ursodeoxycholic Acid helps improve bile flow, reduce bilirubin levels, and delay the need for liver transplantation in many patients.\n\n2. Cholestatic Liver Diseases:\n\nIt is used to treat cholestatic conditions where bile secretion is impaired, such as:\n\nIntrahepatic cholestasis during pregnancy\n\nDrug-induced cholestasis\n\nChronic cholestatic hepatitis\n\nPost-surgical biliary obstruction\n\n3. Gallstone Dissolution (Cholesterol Gallstones):\n\nUrsodeoxycholic Acid 600 mg is effective in dissolving small, non-calcified cholesterol gallstones in patients who cannot undergo surgery. It works by reducing cholesterol saturation in bile, gradually breaking down gallstones over several months.\n\n4. Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH):\n\nIn patients with fatty liver or metabolic liver disorders, UDCA helps improve liver enzyme levels and reduces oxidative stress, supporting better liver health.\n\n5. Bile Reflux Gastritis:\n\nUDCA is used to relieve symptoms caused by bile reflux into the stomach, such as epigastric pain, bloating, and nausea.\n\n6. Cystic Fibrosis-Related Liver Disease:\n\nIt can be used to improve bile flow and prevent hepatic complications in patients with cystic fibrosis.\n\n7. Post Liver Transplantation:\n\nUDCA is sometimes used as supportive therapy to prevent graft-related cholestasis and maintain optimal liver function after transplantation.\n\nKey Benefits of Ursodeoxycholic Acid 600 mg\n1. Promotes Healthy Liver Function\n\nUrsodeoxycholic Acid supports liver detoxification and enhances bile secretion, reducing bile stasis and protecting hepatocytes from toxic damage.\n\n2. Dissolves Cholesterol Gallstones Naturally\n\nUnlike surgical interventions, UDCA provides a non-invasive way to dissolve cholesterol gallstones, especially in patients unfit for surgery.\n\n3. Protects Liver Cells from Damage\n\nUDCA stabilizes the hepatocyte membrane and reduces cell injury caused by bile acids, alcohol, or medications.\n\n4. Reduces Inflammation and Fibrosis\n\nIts anti-inflammatory and antifibrotic properties help slow down the progression of chronic liver diseases.\n\n5. Regulates Cholesterol Levels\n\nUrsodeoxycholic Acid lowers bile cholesterol concentration, which helps maintain a balanced lipid profile and prevents gallstone formation.\n\n6. Supports Recovery in Liver Disorders\n\nIn patients with hepatitis, fatty liver, or cirrhosis, UDCA helps improve liver enzyme levels (ALT, AST, ALP), signaling better liver recovery.\n\n7. Improves Digestive Function\n\nBy improving bile flow, UDCA enhances fat digestion and reduces symptoms like bloating, nausea, and postprandial discomfort.\n\n8. Safe for Long-Term Use\n\nWhen prescribed under medical supervision, Ursodeoxycholic Acid 600 mg is well-tolerated and safe for prolonged treatment of chronic liver diseases.\n\nDosage and Administration\n\nRecommended Dose: The typical adult dose of Ursodeoxycholic Acid ranges between 8–12 mg per kilogram of body weight per day, which equals about 600 mg once or twice daily depending on the patient’s condition.\n\nFormulation: Tablet form (Ursodeoxycholic Acid 600 mg)\n\nMode of Administration: Oral\n\nTiming: It should be taken with meals to enhance absorption and reduce gastrointestinal side effects.\n\nTreatment Duration:\n\nFor gallstone dissolution, therapy may last for 6 months to 2 years.\n\nFor chronic liver conditions, treatment may be long-term or lifelong under physician guidance.\n\nImportant Note:\nThe dosage should be individualized based on body weight, liver function, and medical condition. Patients must not self-medicate and should take the medicine only as prescribed by a healthcare professional.\n\nPrecautions and Warnings\n\nBefore using Ursodeoxycholic Acid 600 mg, patients should consider the following precautions:\n\nMedical Supervision Required:\nAlways use this medicine under the guidance of a doctor, particularly if you have a history of severe liver or gallbladder disease.\n\nAvoid in Certain Gallstones:\nUDCA is not effective for calcified or pigment gallstones.\n\nPregnancy and Breastfeeding:\nWhile UDCA is considered relatively safe during pregnancy, it should only be used when prescribed by a physician. Minimal amounts may pass into breast milk.\n\nMonitor Liver Function:\nRegular liver function tests (LFTs) are advised during treatment to monitor therapeutic response and liver health.\n\nDrug Interactions:\nAvoid concurrent use with:\n\nAluminum-based antacids (reduce UDCA absorption)\n\nCholestyramine or Colestipol (interfere with bile acid absorption)\n\nCiclosporin or Estrogens (may alter bile composition)\n\nAlcohol Consumption:\nAlcohol can strain the liver and reduce the effectiveness of UDCA therapy. Patients should limit or avoid alcohol during treatment.\n\nGastrointestinal Disorders:\nUse with caution in patients with peptic ulcer, severe diarrhea, or gastrointestinal inflammation.\n\nPossible Side Effects of Ursodeoxycholic Acid 600 mg\n\nUrsodeoxycholic Acid is generally well-tolerated, but some patients may experience mild to moderate side effects. These are typically temporary and improve as the body adjusts to the medication.\n\nCommon Side Effects:\n\nDiarrhea or loose stools\n\nNausea and vomiting\n\nAbdominal discomfort\n\nIndigestion or bloating\n\nHeadache\n\nDizziness\n\nLess Common Side Effects:\n\nRash or itching (urticaria)\n\nIncreased liver enzymes (temporary)\n\nBack pain or joint pain\n\nCough or upper respiratory infection symptoms\n\nRare but Serious Side Effects:\n\nSevere right upper abdominal pain (may indicate gallstone complications)\n\nJaundice or dark urine (signs of liver stress)\n\nPersistent diarrhea or dehydration\n\nAllergic reaction (swelling, rash, or shortness of breath)\n\nNote:\nIf any of these side effects persist or worsen, it is important to inform your doctor immediately. Never stop or alter the dosage without consulting your healthcare provider.\n\nSafety in Special Populations\nPregnancy:\n\nUDCA is sometimes used to treat intrahepatic cholestasis of pregnancy (ICP) under strict medical supervision. While generally safe, dosage adjustment and monitoring are essential.\n\nLactation:\n\nIt is considered safe in breastfeeding mothers as minimal quantities are excreted into breast milk.\n\nElderly Patients:\n\nNo specific dosage adjustment is needed, but liver function should be monitored regularly.\n\nChildren:\n\nUrsodeoxycholic Acid can be prescribed in pediatric doses for liver-related disorders, particularly biliary atresia, under pediatric supervision.\n\nStorage and Handling\n\nStore in a cool, dry place below 25°C.\n\nProtect from moisture and direct sunlight.\n\nKeep out of reach of children.\n\nDo not use after the expiry date printed on the pack.\n\nClinical Efficacy and Research Insights\n\nClinical studies across India and globally have confirmed the efficacy of Ursodeoxycholic Acid in managing chronic liver and biliary diseases. Long-term use of UDCA has shown:\n\nImprovement in liver enzyme profiles (AST, ALT, ALP).\n\nReduction in bilirubin levels in cholestatic conditions.\n\nDelay in disease progression in primary biliary cholangitis.\n\nReduction in gallstone size and formation rate with consistent therapy.\n\nBetter quality of life scores among patients with chronic liver conditions.\n\nIts established safety profile and biochemical benefits make Ursodeoxycholic Acid a cornerstone therapy in hepatology.\n\nLifestyle and Dietary Recommendations During Treatment\n\nTo enhance the effectiveness of UDCA therapy and support liver health, patients are advised to:\n\nMaintain a Balanced Diet:\nInclude fresh fruits, vegetables, whole grains, and lean proteins. Avoid fatty, fried, and processed foods.\n\nStay Hydrated:\nDrink sufficient water to aid digestion and toxin elimination.\n\nLimit Alcohol and Caffeine:\nBoth can strain liver metabolism and interfere with medication effectiveness.\n\nExercise Regularly:\nModerate physical activity helps improve liver function and reduce fat accumulation.\n\nAvoid Self-Medication:\nConsult your doctor before using any over-the-counter supplements or herbal products.\n\nFrequently Asked Questions (FAQs)\n\nQ1. How long should Ursodeoxycholic Acid 600 mg be taken?\nThe duration depends on your condition. For gallstone dissolution, treatment may last 6–24 months. For chronic liver diseases, long-term therapy may be recommended.\n\nQ2. Can Ursodeoxycholic Acid cure liver disease completely?\nWhile it does not cure liver disease, UDCA can slow its progression, protect liver cells, and improve biochemical and clinical outcomes.\n\nQ3. Can I take Ursodeoxycholic Acid on an empty stomach?\nIt is best taken with food to enhance absorption and minimize stomach upset.\n\nQ4. Does it interact with other medications?\nYes. Antacids, cholesterol-binding resins, and estrogens may interfere with UDCA absorption or activity. Always inform your doctor about all medications you’re taking.\n\nQ5. How long does it take to see results?\nLiver function improvement can often be observed within a few weeks, but gallstone dissolution may take several months of consistent use.\n\nConclusion\n\nUrsodeoxycholic Acid 600 mg is a trusted and clinically validated therapy for various liver and gallbladder conditions. Its unique ability to enhance bile flow, protect liver cells, and dissolve cholesterol gallstones makes it an indispensable part of hepatology treatment protocols.", "price": 1385.0, "discountamount": 415.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2195, "imageuri": "https://productimages.withfloats.com/actual/69099314f017379146dfffdc.png", "tileimageuri": "https://productimages.withfloats.com/tile/69099314f017379146dfffdc.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-03T07:18:55.866Z", "updatedon": "2025-12-09T06:10:34.413Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ursodeoxycholic-acid-600-mg/2195", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Steris healthcare Pvt Ltd", "category": "GASTROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-12-02T06:31:16.051Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }